Month: February 2021

 PRESS RELASE _NEXANS TO BECOME THE FIRST ELECTRIFICATION PURE PLAYERElectrify the Future – Nexans operational model focused on Electrification value chain from generation of energy to transmission and distribution up to usage of energySimplify to amplify – Nexans will focus on four sectors and scale-up through organic and inorganic amplification200 million euros investment in Subsea high voltage by 2023 – Nexans will invest in Norway and in the USA to address the exponential growth of sustainable electrification2024 financial ambitions outlined – Nexans will rotate portfolio towards pure electrification, scale-up in value to significantly step-up performance and cash flow generation while maintaining a robust balance sheet and committing to a progressive dividendParis, February 17, 2021 – Nexans is hosting today...

 COMMUNIQUÉ DE PRESSE_NEXANS A POUR AMBITION DE DEVENIR LE PREMIER PURE PLAYER DE L’ÉLECTRIFICATIONElectrifier le futur – un modèle opérationnel centré sur la chaîne de valeur de l’électrification couvrant de la production d’énergie jusqu’à sa transmission, sa distribution et sa consommationSimplifier pour amplifier – Nexans va se concentrer sur quatre secteurs et accélérer sa création de valeur grâce à de la croissance organique et inorganique200 millions d’euros d’investissement en Haute tension sous-marine à horizon 2023 – Nexans investira en Norvège et aux États-Unis pour accompagner la croissance exponentielle de l’électrification durableObjectifs financiers 2024 – Nexans va réorienter son portefeuille vers l’électrification, augmenter en valeur pour accroître significativement sa performance, tout en maintenant...

CARGOTEC CORPORATION, PRESS RELEASE, 17 FEBRUARY 2021 AT 3 PM (EET)Kalmar, part of Cargotec, has been awarded a contract to supply Hutchison Ports ECT Rotterdam (ECT) with a total of 10 hybrid straddle carriers for its ECT Delta terminal in Rotterdam, the Netherlands. The order was booked in Cargotec’s 2021 Q1 order intake, with delivery expected to be completed during Q3 of 2021.Hutchison Ports ECT Delta, located on the North Sea coast of Rotterdam, is one of Europe’s largest container terminals and is capable of handling the latest generation of ultra-large container vessels without any restrictions. The terminal benefits from frequent connections with more than 100 ports across Europe, Asia and North Africa. ECT Delta uses its fleet of straddle carriers for the horizontal transportation on the landside, for loading and unloading...

CARGOTEC OYJ, LEHDISTÖTIEDOTE, 17.2.2021 KLO 15Cargoteciin kuuluva Kalmar on sopinut 10 hybridikonttilukin toimittamisesta Hutchison Portsin Rotterdamissa, Alankomaissa sijaitsevaan ECT Delta -terminaaliin. Tilaus on kirjattu Cargotecin vuoden 2021 ensimmäisen neljänneksen tilauskantaan, ja toimitus tapahtuu saman vuoden kolmannella neljänneksellä. Pohjanmeren rannikolla Rotterdamissa sijaitseva Hutchison Ports ECT Delta on yksi Euroopan suurimmista konttiterminaaleista, joka pystyy palvelemaan uusimman sukupolven suurimpia konttialuksia. Terminaalilla on jatkuva yhteys yli 100 satamaan Euroopassa, Aasiassa ja Pohjois-Afrikassa. ECT Delta käyttää konttilukkeja konttien kuljetukseen laiturialueella ja konttikentällä sekä kuorma-autojen lastaamiseen ja purkamiseen.Kalmarin hybridikonttilukki vähentää sekä terminaalien polttoaineen kulutusta...

Appointment to strengthen clinical development capabilities with a strategic and visionary immunotherapy leader as Cue Biopharma advances its pipeline of drug development programsCAMBRIDGE, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells within the patient’s body, announced today it has appointed Dr. Matteo Levisetti as senior vice president of clinical development, effective February 22, 2021. Dr. Levisetti joins Cue Biopharma with extensive drug development experience in the pharmaceutical and biotech industries, where he led global clinical development and regulatory strategies for multiple clinical development programs in immuno-oncology, and autoimmune...

LA JOLLA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced a trading agreement with Technical Risk Underwriters (“TRU”), a subsidiary of Ryan Specialty Group, LLC. TRU specializes in underwriting insurance products for complex construction projects and is a managing general underwriter. Palomar’s surplus lines subsidiary, Palomar Excess and Surplus Insurance Company (“PESIC”), acts as another important market for TRU and participates in select new business written by the managing general underwriter.Through the agreement with TRU, Palomar gains access to the larger limit Builder’s Risk markets, which the Company historically has not pursued. This expansion includes access to TRU’s national wholesale distribution channels and years of industry relationships....

AUSTIN, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) — February is recognized as Black History Month, a time to honor the contributions of Black Americans to culture and society while elevating the voices of those fighting for equity and justice. This month, Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, is underscoring its commitment to addressing racial and ethnic disparities in ovarian cancer risk assessment. We aim to ensure that our testing options give women of ALL ages, stages, races and ethinicities a chance to access the best solutions available for personalized risk of ovarian cancer at the earliest stage when it matters most.“Aspira has built a patient advisory board to ensure the voice of the patient is central to all the great work the company is doing to change the story of ovarian...

Versus brings its real-world prizing software to live events, partnering with the company that powers interactive experiences for over 50% of NFL, MLB, NHL, and NBA teamsLOS ANGELES, Feb. 17, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus”) (Nasdaq: VS) (CSE:VS) (FRANKFURT:BMVB) today announced a partnership agreement with Xcite Interactive (“Xcite”), a world leader in interactive audience engagement. Audiences will be able to win real-world prizes while watching sports, playing mobile games, and watching streams on their TVs and mobile devices.Xcite’s technology has powered interactive media experiences for major sports leagues like the NFL, NBA, NHL MLB, and NCAA, as well as events like the Olympics, the World Cup, X-Games, Formula1, and corporate events around the world. The interactive media platform has delivered experiential...

Lisa DeFrancesco, Senior Vice President, Corporate Affairs & Investor Relations, will join Intercept’s Executive Leadership TeamNEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced the appointment of Linda Richardson as Chief Commercial Officer. Ms. Richardson was previously Senior Vice President and Head of the Global Cholestasis Program at Intercept, where she has guided long-range planning for Intercept’s rare disease franchise in PBC and other cholestatic liver diseases since 2018.“Linda’s deep global commercial experience makes her an ideal leader for Intercept’s next phase of growth and development,” said Jerry Durso, President...